Carisma Therapeutics News and Activities

Carisma Therapeutics is a company listed under the stock ticker CARM (US).

View the org chart displaying its 9 main executives

Most searched biographies at Carisma Therapeutics

• Steven Kelly, President and Chief Executive Officer
• David Scadden, Director
• Marella Thorell, Director

Create your alert
to follow the executive moves at Carisma Therapeutics.

Carisma Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Carisma Therapeutics

• Press Releases | Carisma
• Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference | Carisma Therapeutics Inc.
• Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Carisma Therapeutics Inc.
• Press Releases | Carisma Therapeutics
• Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights | Carisma Therapeutics Inc.
• Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors
• Press Releases | Carisma Therapeutics
• Press Releases | Carisma Therapeutics
• View more press releases Close

Social media about Carisma Therapeutics

• Carisma Therapeutics on Wikipedia, Google News & Yahoo Finance
• Carisma Therapeutics on LinkedIn, X (Twitter) & YouTube